Robeco BP US Premium Equities EH £Register to Unlock Ratings |
Performance History | 31/03/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 2.2 | 23.0 | -5.8 | 9.9 | 8.4 | |
+/-Cat | - | - | - | - | - | |
+/-B’mrk | - | - | - | - | - | |
Category: Other Equity | ||||||
Category Benchmark: - |
Key Stats | ||
NAV 26/04/2024 | GBP 317.31 | |
Day Change | 0.14% | |
Morningstar Category™ | Other Equity | |
IA (formerly IMA) Sector | - | |
ISIN | LU0432313756 | |
Fund Size (Mil) 29/04/2024 | USD 5168.89 | |
Share Class Size (Mil) 31/03/2024 | GBP 1.75 | |
Max Initial Charge | 5.00% | |
Ongoing Charge 18/02/2022 | 1.71% |
Investment Objective: Robeco BP US Premium Equities EH £ |
The aim of the Sub-fund is to provide long term capital growth while at the same time promoting certain ESG (i.e. Environmental, Social and corporate Governance) characteristics and integrating sustainability risks in the investment process. The Sub-fund will invest at least two-thirds of its total assets to equities of companies incorporated or exercising a preponderant part of their economic activities in the United States. The Sub-fund will focus on investing in companies that are undervalued and combine attractive valuation with a catalyst for change. These companies can be both large caps as well as midcaps and small caps. |
Returns | ||||||||||||||||
|
Management | ||
Manager Name Start Date | ||
Duilio Ramallo 03/10/2005 | ||
Inception Date 01/06/2009 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
Russell 3000 Value TR USD | - |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Robeco BP US Premium Equities EH £ | 29/02/2024 |
|
|
Top 5 Holdings | Sector | % |
Johnson & Johnson | Healthcare | 2.29 |
JPMorgan Chase & Co | Financial Services | 2.03 |
AbbVie Inc | Healthcare | 1.95 |
CRH PLC | Basic Materials | 1.91 |
Alphabet Inc Class A | Communication Services | 1.86 |
Increase Decrease New since last portfolio | ||
Robeco BP US Premium Equities EH £ |